Compare SACH & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SACH | DRIO |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | 27 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.5M | 60.6M |
| IPO Year | N/A | 2013 |
| Metric | SACH | DRIO |
|---|---|---|
| Price | $0.96 | $7.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $2.00 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 251.6K | 9.0K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | ★ 19.23% | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | $145.00 | $20.27 |
| Revenue Next Year | $6.80 | $47.58 |
| P/E Ratio | ★ N/A | $5.40 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $0.90 | $0.38 |
| 52 Week High | $1.45 | $17.74 |
| Indicator | SACH | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 40.91 | 51.48 |
| Support Level | $0.91 | $6.13 |
| Resistance Level | $1.12 | $9.24 |
| Average True Range (ATR) | 0.03 | 0.54 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 28.42 | 60.10 |
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.